Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308308727> ?p ?o ?g. }
- W4308308727 endingPage "59" @default.
- W4308308727 startingPage "50" @default.
- W4308308727 abstract "The social withdrawal of many patients with psychosis can be conceptualised as agoraphobic avoidance due to a range of long-standing fears. We hypothesised that greater severity of agoraphobic avoidance is associated with higher levels of psychiatric symptoms and lower levels of quality of life. We also hypothesised that patients with severe agoraphobic avoidance would experience a range of benefits from an automated virtual reality (VR) therapy that allows them to practise everyday anxiety-provoking situations in simulated environments.345 patients with psychosis in a randomised controlled trial were categorised into average, moderate, high, and severe avoidance groups using the Oxford Agoraphobic Avoidance Scale. Associations of agoraphobia severity with symptom and functioning variables, and response over six months to brief automated VR therapy (gameChange), were tested.Greater severity of agoraphobic avoidance was associated with higher levels of persecutory ideation, auditory hallucinations, depression, hopelessness, and threat cognitions, and lower levels of meaningful activity, quality of life, and perceptions of recovery. Patients with severe agoraphobia showed the greatest benefits with gameChange VR therapy, with significant improvements at end of treatment in agoraphobic avoidance, agoraphobic distress, ideas of reference, persecutory ideation, paranoia worries, recovering quality of life, and perceived recovery, but no significant improvements in depression, suicidal ideation, or health-related quality of life.Patients with psychosis with severe agoraphobic avoidance, such as being unable to leave the home, have high clinical need. Automated VR therapy can deliver clinical improvement in agoraphobia for these patients, leading to a number of wider benefits." @default.
- W4308308727 created "2022-11-10" @default.
- W4308308727 creator A5000177470 @default.
- W4308308727 creator A5018052907 @default.
- W4308308727 creator A5018547256 @default.
- W4308308727 creator A5020720630 @default.
- W4308308727 creator A5021613632 @default.
- W4308308727 creator A5022610470 @default.
- W4308308727 creator A5025225625 @default.
- W4308308727 creator A5028450636 @default.
- W4308308727 creator A5029652042 @default.
- W4308308727 creator A5030418835 @default.
- W4308308727 creator A5039877998 @default.
- W4308308727 creator A5041636518 @default.
- W4308308727 creator A5042682993 @default.
- W4308308727 creator A5046567545 @default.
- W4308308727 creator A5057734395 @default.
- W4308308727 creator A5059411335 @default.
- W4308308727 creator A5067804061 @default.
- W4308308727 creator A5073444495 @default.
- W4308308727 creator A5075403636 @default.
- W4308308727 creator A5078772595 @default.
- W4308308727 date "2022-12-01" @default.
- W4308308727 modified "2023-09-30" @default.
- W4308308727 title "Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial" @default.
- W4308308727 cites W1980623059 @default.
- W4308308727 cites W1990166011 @default.
- W4308308727 cites W2021832371 @default.
- W4308308727 cites W2022387798 @default.
- W4308308727 cites W2115041319 @default.
- W4308308727 cites W2122586240 @default.
- W4308308727 cites W2127516619 @default.
- W4308308727 cites W2128269126 @default.
- W4308308727 cites W2132322340 @default.
- W4308308727 cites W2148083007 @default.
- W4308308727 cites W2745578526 @default.
- W4308308727 cites W2776620435 @default.
- W4308308727 cites W2935528091 @default.
- W4308308727 cites W2961631722 @default.
- W4308308727 cites W2970979717 @default.
- W4308308727 cites W2980712812 @default.
- W4308308727 cites W3025492705 @default.
- W4308308727 cites W3175812695 @default.
- W4308308727 cites W4210347833 @default.
- W4308308727 cites W4212764635 @default.
- W4308308727 cites W4223481471 @default.
- W4308308727 doi "https://doi.org/10.1016/j.schres.2022.10.008" @default.
- W4308308727 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36343472" @default.
- W4308308727 hasPublicationYear "2022" @default.
- W4308308727 type Work @default.
- W4308308727 citedByCount "2" @default.
- W4308308727 countsByYear W43083087272023 @default.
- W4308308727 crossrefType "journal-article" @default.
- W4308308727 hasAuthorship W4308308727A5000177470 @default.
- W4308308727 hasAuthorship W4308308727A5018052907 @default.
- W4308308727 hasAuthorship W4308308727A5018547256 @default.
- W4308308727 hasAuthorship W4308308727A5020720630 @default.
- W4308308727 hasAuthorship W4308308727A5021613632 @default.
- W4308308727 hasAuthorship W4308308727A5022610470 @default.
- W4308308727 hasAuthorship W4308308727A5025225625 @default.
- W4308308727 hasAuthorship W4308308727A5028450636 @default.
- W4308308727 hasAuthorship W4308308727A5029652042 @default.
- W4308308727 hasAuthorship W4308308727A5030418835 @default.
- W4308308727 hasAuthorship W4308308727A5039877998 @default.
- W4308308727 hasAuthorship W4308308727A5041636518 @default.
- W4308308727 hasAuthorship W4308308727A5042682993 @default.
- W4308308727 hasAuthorship W4308308727A5046567545 @default.
- W4308308727 hasAuthorship W4308308727A5057734395 @default.
- W4308308727 hasAuthorship W4308308727A5059411335 @default.
- W4308308727 hasAuthorship W4308308727A5067804061 @default.
- W4308308727 hasAuthorship W4308308727A5073444495 @default.
- W4308308727 hasAuthorship W4308308727A5075403636 @default.
- W4308308727 hasAuthorship W4308308727A5078772595 @default.
- W4308308727 hasBestOaLocation W43083087271 @default.
- W4308308727 hasConcept C118552586 @default.
- W4308308727 hasConcept C126322002 @default.
- W4308308727 hasConcept C139265228 @default.
- W4308308727 hasConcept C15744967 @default.
- W4308308727 hasConcept C168563851 @default.
- W4308308727 hasConcept C2778251122 @default.
- W4308308727 hasConcept C2778678127 @default.
- W4308308727 hasConcept C2779727114 @default.
- W4308308727 hasConcept C2779951463 @default.
- W4308308727 hasConcept C2780712732 @default.
- W4308308727 hasConcept C2781105514 @default.
- W4308308727 hasConcept C542102704 @default.
- W4308308727 hasConcept C558461103 @default.
- W4308308727 hasConcept C70410870 @default.
- W4308308727 hasConcept C71924100 @default.
- W4308308727 hasConceptScore W4308308727C118552586 @default.
- W4308308727 hasConceptScore W4308308727C126322002 @default.
- W4308308727 hasConceptScore W4308308727C139265228 @default.
- W4308308727 hasConceptScore W4308308727C15744967 @default.
- W4308308727 hasConceptScore W4308308727C168563851 @default.
- W4308308727 hasConceptScore W4308308727C2778251122 @default.
- W4308308727 hasConceptScore W4308308727C2778678127 @default.
- W4308308727 hasConceptScore W4308308727C2779727114 @default.
- W4308308727 hasConceptScore W4308308727C2779951463 @default.